Klaria Pharma Holding AB (publ.)

Klaria Pharma Holding AB (publ.)verified

KLAR.ST

Price:

$0.54

Market Cap:

$166.11M

Klaria Pharma Holding AB (publ.) operates as a pharmaceutical company in Sweden and internationally. It offers Sumatriptan for the treatment of migraine; and Midazolam for acute epilepsy. The company's clinical phase products include Epinephrine/Adrenaline for the treatment of acute allergic reaction; Naloxone for opioid overdose; and Ketamine for acute pain and depression. It also focuses on the commercialization of cannabis/cannabinoids, including THC and CBD for medical and recreational applications. The company was founded in 2014 and is based in Uppsala, Sweden.

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2015-10-21

Stock Exchange

STO

Ticker

KLAR.ST

The Enterprise Value as of December 2025 (TTM) for Klaria Pharma Holding AB (publ.) (KLAR.ST) is 164.76M

According to Klaria Pharma Holding AB (publ.)’s latest financial reports and current stock price. The company's current Enterprise Value is 164.76M. This represents a change of 59.37% compared to the average of 103.38M of the last 4 quarters.

Klaria Pharma Holding AB (publ.) (KLAR.ST) Historical Enterprise Value (quarterly & annually)

How has KLAR.ST Enterprise Value performed in the past?

The mean historical Enterprise Value of Klaria Pharma Holding AB (publ.) over the last ten years is 186.60M. The current 164.76M Enterprise Value has changed 8.73% with respect to the historical average. Over the past ten years (40 quarters), KLAR.ST's Enterprise Value was at its highest in in the June 2021 quarter at 413.38M. The Enterprise Value was at its lowest in in the March 2024 quarter at 28.99M.

Quarterly (TTM)
Annual

Average

186.60M

Median

191.96M

Minimum

63.61M

Maximum

347.14M

Klaria Pharma Holding AB (publ.) (KLAR.ST) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Klaria Pharma Holding AB (publ.) Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 181.80%

Maximum Annual Enterprise Value = 347.14M

Minimum Annual Increase = -35471.94%

Minimum Annual Enterprise Value = 63.61M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202464.22M0.96%
202363.61M-6.08%
202267.72M-80.49%
2021347.14M30.76%
2020265.48M85.55%
2019143.08M-51.25%
2018293.50M-0.49%
2017294.96M22.47%
2016240.85M181.80%
201585.47M-35471.94%

Klaria Pharma Holding AB (publ.) (KLAR.ST) Average Enterprise Value

How has KLAR.ST Enterprise Value performed in the past?

The current Enterprise Value of Klaria Pharma Holding AB (publ.) (KLAR.ST) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

65.18M

5-year avg

161.63M

10-year avg

186.60M

Klaria Pharma Holding AB (publ.) (KLAR.ST) Enterprise Value vs. Peers

How is KLAR.ST’s Enterprise Value compared to its peers?

Klaria Pharma Holding AB (publ.)’s Enterprise Value is greater than AcuCort AB (104.48M), less than Enorama Pharma AB (publ) (178.42M), greater than Q-linea AB (publ) (163.33M), greater than Vivesto AB (69.29M), greater than BrainCool AB (publ) (124.50M), less than Alzinova AB (publ) (200.41M), less than Integrum AB (publ) (220.16M), greater than Xbrane Biopharma AB (publ) (21.85M), greater than Isofol Medical AB (publ) (148.95M), greater than SciBase Holding AB (publ) (114.62M),

Build a custom stock screener for Klaria Pharma Holding AB (publ.) (KLAR.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Klaria Pharma Holding AB (publ.) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Klaria Pharma Holding AB (publ.) (KLAR.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Klaria Pharma Holding AB (publ.) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Klaria Pharma Holding AB (publ.)'s Enterprise Value?

What is the highest Enterprise Value for Klaria Pharma Holding AB (publ.) (KLAR.ST)?

What is the 3-year average Enterprise Value for Klaria Pharma Holding AB (publ.) (KLAR.ST)?

What is the 5-year average Enterprise Value for Klaria Pharma Holding AB (publ.) (KLAR.ST)?

How does the current Enterprise Value for Klaria Pharma Holding AB (publ.) (KLAR.ST) compare to its historical average?